Question-and-Answer Session
Operator
(Operator Instructions). Thank you. Our first question is coming from Bruce Cranna with Leerink Swann.
Bruce Cranna - Leerink Swann LLC
Hi good morning guys.
David Elkins
Good morning.
Vincent Forlenza
Good morning.
Bruce Cranna - Leerink Swann LLC
Dave, can you just run through the gross margin pickup year-over-year again by pieces I missed some of those?
David Elkins
Okay. For year-to-date or did you want the third quarter?
Bruce Cranna - Leerink Swann LLC
Just the quarter.
David Elkins
Just the quarter, so revenue growth year-over-year that is 5 percentage points that related to performance. 1.4%...
Vincent Forlenza
He's asking about
Bruce Cranna - Leerink Swann LLC
No. I'm sorry yes the gross margin
David Elkins
So the gross margin moved from 51% to 52.8%, performance was 0.7, hedge gained was 0.7 and currency was 0.4.
Bruce Cranna - Leerink Swann LLC
And did you make a comment on resin in there, if you did I missed it?
David Elkins
No, I did not.
Bruce Cranna - Leerink Swann LLC
Okay. And then on flu side, can you quantify the actual uptick in the quarter in dollars for flu sales and weather or not you thinks that's, I guess indicative of what the next couple of quarters might look like or should we think about that moving back down.
Vincent Forlenza
Bruce this is Vince. So I'll take the diagnostics piece of it. Diagnostics had about $8 million in flu sales in the quarter, with bulk of that 5 million being at ex U.S. And then medical had... I'm sorry 5 U.S., ex switched 5 U.S. for the flu products. Bill on the medical side?
William Kozy
$5 million of revenue in medical business in the third quarter.
Vincent Forlenza
Now in terms of looking forward it's difficult to predict exactly what's going to happen here, but we do expect that we will see on a medical side in the syringe area ongoing orders for flu products, in fact Bill do you want to comment on the balance of the year.
William Kozy
Sure as of July 23rd, in terms of -- we've received about $45 million of firm commitments, 27 million of those are in the medical surgical business the remaining $18 million went to the pharmaceuticals systems business. As Vince, has already mentioned we shift $5 million for those orders in the 3Q and we estimate shipment of another $27 million in the fourth quarter with the remainder to follow-up and first follow FY '10.
- To read the full transcript on Seeking Alpha, click here »
